Breast-specific gamma imaging developer Dilon Diagnostics has signed a three-year sales agreement with mammography information systems developer PenRad Technologies.
Under the terms of the pact, Dilon's portfolio now will include the PenRad mammography information system (MIS) and also Volpara, a quantitative breast density assessment tool designed to convert a qualitative breast x-ray image into quantitative data.Dilon inks sales pact with PenRad
Latest in Breast
Women who skip first mammogram more likely to die of breast cancer
September 24, 2025
Study finds AI not cost-effective for breast cancer screening
September 24, 2025
Adding MBI to DBT finds more breast cancers
September 23, 2025
Echogenic rind on breast ultrasound holds diagnostic significance
September 17, 2025